- Home
- PBYI vs EBMT Comparison
PBYI vs EBMT Comparison
Compare PBYI & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- EBMT
- Stock Information
- Founded
- PBYI 2010
- EBMT 1922
- Country
- PBYI United States
- EBMT United States
- Employees
- PBYI N/A
- EBMT N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- EBMT Major Banks
- Sector
- PBYI Health Care
- EBMT Finance
- Exchange
- PBYI Nasdaq
- EBMT Nasdaq
- Market Cap
- PBYI 153.2M
- EBMT 139.5M
- IPO Year
- PBYI N/A
- EBMT N/A
- Fundamental
- Price
- PBYI $3.00
- EBMT $15.00
- Analyst Decision
- PBYI Strong Buy
- EBMT
- Analyst Count
- PBYI 1
- EBMT 0
- Target Price
- PBYI $7.00
- EBMT N/A
- AVG Volume (30 Days)
- PBYI 510.9K
- EBMT 15.9K
- Earning Date
- PBYI 02-27-2025
- EBMT 01-21-2025
- Dividend Yield
- PBYI N/A
- EBMT 3.75%
- EPS Growth
- PBYI 492.79
- EBMT N/A
- EPS
- PBYI 0.47
- EBMT 1.09
- Revenue
- PBYI $243,569,000.00
- EBMT $80,038,000.00
- Revenue This Year
- PBYI N/A
- EBMT N/A
- Revenue Next Year
- PBYI N/A
- EBMT $8.40
- P/E Ratio
- PBYI $6.62
- EBMT $14.03
- Revenue Growth
- PBYI 6.30
- EBMT N/A
- 52 Week Low
- PBYI $2.23
- EBMT $12.32
- 52 Week High
- PBYI $7.73
- EBMT $17.65
- Technical
- Relative Strength Index (RSI)
- PBYI 54.85
- EBMT 24.42
- Support Level
- PBYI $2.73
- EBMT $14.97
- Resistance Level
- PBYI $3.38
- EBMT $17.05
- Average True Range (ATR)
- PBYI 0.21
- EBMT 0.40
- MACD
- PBYI 0.02
- EBMT -0.17
- Stochastic Oscillator
- PBYI 56.06
- EBMT 10.74
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.